What Biotex does

Biotex is a privately-held biotechnology company founded in 1997 and headquartered in Houston, Texas. According to its firmographic profile, the company specializes in the development, launch, and manufacturing of medical and bio-technologies, operating as an integrated player that takes products from concept through commercial production. Biotex is structured as a for-profit private entity with 51-100 employees, placing it in the small-to-mid manufacturer tier typical of niche contract development and manufacturing organizations (CDMOs) or specialty medical device producers.

The company is founder-led: Ashok Gowda has served as founder, President, and CEO since inception, and Andre G. Marquette holds the role of Vice President of Business Development. Public information about specific products, underlying technology platforms, regulatory clearances, customer relationships, pricing, and revenue is not available in the provided sources—the company's website (biotexmedical.com) currently resolves only to a placeholder verification page, and no press releases, partnerships, funding rounds, or third-party coverage were surfaced.

Given the absence of disclosed product details, customer logos, pricing model, or distribution channels, the revenue model and go-to-market mechanics cannot be characterized from the input data. No information is available on whether Biotex operates as a contract manufacturer for external clients, sells proprietary medical devices under its own brand, or some combination. The data gap is material: a meaningful investment thesis would require visibility into product mix, FDA/regulatory status, customer concentration, and unit economics, none of which are present in the supplied material.

Name

Biotex

Website

https://biotexmedical.com

Company type

Private

Founded year

1997

Headcount range

51–100 employees

Short description

Biotex is a private Houston-based biotechnology company founded in 1997 that develops, launches, and manufactures medical and bio-technologies, employing 51-100 people under founder and CEO Ashok Gowda.

Ownership category

akta.pro rank

Product category

Medical Device Manufacturing

NAICS

Biological Product (except Diagnostic) Manufacturing (325414), Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

Biological Products, (No Disgnostic Substances) (2836)

akta.pro primary industry

Biologic API/Drug Substance Manufacturing Services (HLAAAKAA)

akta.pro secondary industries

Process Development & Tech Transfer Services (upstream/downstream) (HLAAAKAF), Bioprocess Development & Scale-Up/Scale-Down Platforms (DoE, high-throughput, modeling) (HLAAAJAF)

Keywords

• Medical device manufacturing
• Biotechnology development
• Biotech contract manufacturing
• Medical technology products
• Medical device commercialization

Headquarters

HQ city

Houston

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Supply Chain, Technology or R&D, Infrastructure

Core offering

Biotex is a biotechnology company that specializes in the development, launch, and manufacturing of medical and bio-technologies. The firm operates as a product development and manufacturing partner, taking medical and biotech innovations from concept through commercialization.

Product overview

No specific product or service details were available in the provided sources. The source material consisted of a supplement industry news article about trends at the Arnold Sports Festival 2026 (unrelated to Biotex specifically) and a placeholder loading page from biotexmedical.com displaying a verification request message.

Differentiator

Problem solved

Functional benefit

Products and services

• Medical and Biotechnology Development and Manufacturing Services

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Recent moves2 records

Broad incumbents

• FUJIFILM Diosynth Biotechnologies: CDMO providing process development and GMP manufacturing for biologics, vaccines, and gene therapies. Comparable to Biotex in bioprocess development and biologics manufacturing, particularly for clients needing scale-up support.
• Samsung Biologics: Large-scale biologics contract manufacturer offering process development, clinical and commercial manufacturing, and fill-finish services. Comparable to Biotex in the biologics manufacturing space, though at materially greater scale.
• Charles River Laboratories: Contract research and biomanufacturing services provider offering process development, GMP manufacturing, and biologic testing. Comparable to Biotex in serving biotech clients across development and manufacturing, with stronger scientific services breadth.
• Catalent: Large CDMO providing biologics development, fill-finish, and commercial manufacturing services for biopharma customers. Comparable to Biotex in serving the development-to-launch lifecycle for medical/biologic products, though Catalent operates globally at much greater scale.
• WuXi Biologics: Global biologics CDMO offering end-to-end discovery, development, and manufacturing services for biologic drug substance and drug product. Comparable in lifecycle coverage and biologic manufacturing focus to Biotex's stated capabilities.
• Lonza Group: Global biopharmaceutical contract development and manufacturing organization (CDMO) offering mammalian and microbial biologics production, process development, and tech transfer — directly comparable to Biotex's described development and manufacturing of bio-technologies, but at vastly larger scale.

Direct peers

• Emergent BioSolutions: Biopharmaceutical company with biomanufacturing services for vaccines, therapeutics, and biologics, including contract and internal manufacturing. Comparable to Biotex in development and manufacturing of medical biotech products.
• AGC Biologics: Mid-to-large scale CDMO providing process development, tech transfer, and GMP manufacturing for biologics and advanced therapies. Closely comparable to Biotex as a contract development and manufacturing partner serving biotech and biopharma clients.

Emerging players

• Vibalogics: Specialized CDMO focused on live virus and viral vector manufacturing for vaccines and gene therapies. Comparable niche-focused biomanufacturing service provider to Biotex, though operating in a more specialized therapeutic modality.
• National Resilience: Emerging biomanufacturing CDMO providing process development and GMP manufacturing services for biologics, vaccines, and advanced therapies. Comparable development-to-launch operating model to Biotex, with broader modality coverage and more recent capital base.

Market position

Strengths3 records

Weaknesses3 records

Competitive moat2 records

Key risks4 records

Key highlights4 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Biotex